Literature DB >> 18787208

Activation of CCAAT/enhancer-binding protein alpha or PU.1 in hematopoietic stem cells leads to their reduced self-renewal and proliferation.

Yumi Fukuchi1, Miyuki Ito, Fumi Shibata, Toshio Kitamura, Hideaki Nakajima.   

Abstract

Previous studies using loss-of-function mutants revealed that CCAAT/enhancer-binding protein alpha (C/EBPalpha) and PU.1 are potential regulators for hematopoietic stem cells (HSCs). To gain further insight into the HSC regulation by C/EBPalpha or PU.1, we used transgenic mice expressing conditional forms of these transcription factors to examine whether their activation alone is sufficient for modulating HSC functions. The activation of C/EBPalpha or PU.1 in HSCs in vitro or in vivo led to their suppression of growth, decreased mixed colony formation, and impaired competitive repopulating activities because of their defective self-renewal. These effects were more prominently observed when C/EBPalpha was activated, and the differentiation capacity to megakaryocytic lineage was selectively impaired upon C/EBPalpha activation. Unexpectedly, the expression of Bmi-1 and HoxB4, well-known regulators for self-renewal of HSCs, was not affected by the activation of C/EBPalpha or PU.1, suggesting that they regulate HSC function through an as yet unknown mechanism. Our data suggest that the activation of C/EBPalpha or PU.1 is sufficient to repress stem cell capacities in HSCs, and their fine-tuned regulation is critical for HSC homeostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787208     DOI: 10.1634/stemcells.2008-0320

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  9 in total

1.  CREB1 is a strong genetic predictor of the variation in exercise heart rate response to regular exercise: the HERITAGE Family Study.

Authors:  Tuomo Rankinen; George Argyropoulos; Treva Rice; D C Rao; Claude Bouchard
Journal:  Circ Cardiovasc Genet       Date:  2010-04-20

2.  Contrasting roles for C/EBPα and Notch in irradiation-induced multipotent hematopoietic progenitor cell defects.

Authors:  Courtney Jo Fleenor; Andrii Ivan Rozhok; Vadym Zaberezhnyy; Divij Mathew; Jihye Kim; Aik-Choon Tan; Irwin David Bernstein; James DeGregori
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277

3.  Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients.

Authors:  Bryce A Manso; Henan Zhang; Molly G Mikkelson; Kimberly A Gwin; Charla R Secreto; Wei Ding; Sameer A Parikh; Neil E Kay; Kay L Medina
Journal:  Leukemia       Date:  2018-10-05       Impact factor: 11.528

4.  Phosphorylation of serine 248 of C/EBPα is dispensable for myelopoiesis but its disruption leads to a low penetrant myeloid disorder with long latency.

Authors:  Marie S Hasemann; Mikkel B Schuster; Anne-Katrine Frank; Kim Theilgaard-Mönch; Thomas Å Pedersen; Claus Nerlov; Bo T Porse
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

5.  Sumoylation of CCAAT/enhancer-binding protein α is implicated in hematopoietic stem/progenitor cell development through regulating runx1 in zebrafish.

Authors:  Hao Yuan; Tao Zhang; Xiaohui Liu; Min Deng; Wenqing Zhang; Zilong Wen; Saijuan Chen; Zhu Chen; Hugues de The; Jun Zhou; Jun Zhu
Journal:  Sci Rep       Date:  2015-03-11       Impact factor: 4.379

6.  DNA methyltransferase 1 functions through C/ebpa to maintain hematopoietic stem and progenitor cells in zebrafish.

Authors:  Xiaohui Liu; Xiaoe Jia; Hao Yuan; Ke Ma; Yi Chen; Yi Jin; Min Deng; Weijun Pan; Saijuan Chen; Zhu Chen; Hugues de The; Leonard I Zon; Yi Zhou; Jun Zhou; Jun Zhu
Journal:  J Hematol Oncol       Date:  2015-02-22       Impact factor: 17.388

7.  Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells.

Authors:  Laure Delestré; Hengxiang Cui; Michela Esposito; Cyril Quiveron; Elena Mylonas; Virginie Penard-Lacronique; Oliver Bischof; Christel Guillouf
Journal:  Haematologica       Date:  2017-09-14       Impact factor: 9.941

8.  Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation.

Authors:  Nouraiz Ahmed; Martin Etzrodt; Philip Dettinger; Tobias Kull; Dirk Loeffler; Philipp S Hoppe; James S Chavez; Yang Zhang; Germán Camargo Ortega; Oliver Hilsenbeck; Hideaki Nakajima; Eric M Pietras; Timm Schroeder
Journal:  J Exp Med       Date:  2021-11-24       Impact factor: 17.579

9.  Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells.

Authors:  Philipp B Staber; Pu Zhang; Min Ye; Robert S Welner; César Nombela-Arrieta; Christian Bach; Marc Kerenyi; Boris A Bartholdy; Hong Zhang; Meritxell Alberich-Jordà; Sanghoon Lee; Henry Yang; Felicia Ng; Junyan Zhang; Mathias Leddin; Leslie E Silberstein; Gerald Hoefler; Stuart H Orkin; Berthold Göttgens; Frank Rosenbauer; Gang Huang; Daniel G Tenen
Journal:  Mol Cell       Date:  2013-02-08       Impact factor: 17.970

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.